FI20031078A0 - Farmaceutiska kompositioner med antibiotisk aktivitet - Google Patents

Farmaceutiska kompositioner med antibiotisk aktivitet

Info

Publication number
FI20031078A0
FI20031078A0 FI20031078A FI20031078A FI20031078A0 FI 20031078 A0 FI20031078 A0 FI 20031078A0 FI 20031078 A FI20031078 A FI 20031078A FI 20031078 A FI20031078 A FI 20031078A FI 20031078 A0 FI20031078 A0 FI 20031078A0
Authority
FI
Finland
Prior art keywords
antibiotically
assayed
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
FI20031078A
Other languages
English (en)
Finnish (fi)
Other versions
FI120080B (sv
FI20031078A (sv
Inventor
Luca Rampoldi
Luca Pirrone
Sarah Faccin
Alessandro Grassano
Giovanni Gurrieri
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27638551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20031078(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of FI20031078A0 publication Critical patent/FI20031078A0/sv
Publication of FI20031078A publication Critical patent/FI20031078A/sv
Application granted granted Critical
Publication of FI120080B publication Critical patent/FI120080B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
FI20031078A 2002-08-01 2003-07-16 Farmaceutiska kompositioner med antibiotisk aktivitet FI120080B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20021725 2002-08-01
IT001725A ITMI20021725A1 (it) 2002-08-01 2002-08-01 Composizioni farmaceutiche ad attivita' antibiotica.

Publications (3)

Publication Number Publication Date
FI20031078A0 true FI20031078A0 (sv) 2003-07-16
FI20031078A FI20031078A (sv) 2004-02-02
FI120080B FI120080B (sv) 2009-06-30

Family

ID=27638551

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20031078A FI120080B (sv) 2002-08-01 2003-07-16 Farmaceutiska kompositioner med antibiotisk aktivitet

Country Status (29)

Country Link
US (1) US7303755B2 (sv)
JP (1) JP4395338B2 (sv)
KR (1) KR100966977B1 (sv)
AT (1) AT500521B1 (sv)
BE (1) BE1017903A3 (sv)
BR (1) BRPI0302496C1 (sv)
CA (1) CA2434927C (sv)
CH (1) CH696718A5 (sv)
CO (1) CO5480297A1 (sv)
CZ (1) CZ305023B6 (sv)
DE (1) DE10334820B4 (sv)
DK (1) DK178348B1 (sv)
ES (1) ES2224869B1 (sv)
FI (1) FI120080B (sv)
FR (1) FR2852845B1 (sv)
GR (1) GR20030100300A (sv)
HR (1) HRP20030618B1 (sv)
HU (1) HU230575B1 (sv)
IL (1) IL156615A (sv)
IT (1) ITMI20021725A1 (sv)
NL (1) NL1023790C2 (sv)
PL (1) PL209644B1 (sv)
PT (1) PT102995B (sv)
RU (1) RU2333000C2 (sv)
SE (1) SE527466C2 (sv)
SI (1) SI21259B (sv)
SK (1) SK287201B6 (sv)
TR (1) TR200301248A2 (sv)
ZA (1) ZA200305040B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE740685C (de) * 1941-04-11 1943-10-26 Voigt & Haeffner Ag Viertakt-Regelschalter fuer Parallel-, Einzel- und Reihenschaltung von Heizwiderstaenden
ES2244333B1 (es) * 2004-05-18 2006-08-01 Simbec Iberica, Sl Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
PT2482812T (pt) 2009-10-02 2023-01-24 Boehringer Ingelheim Int Composições farmacêuticas compreendendo bi-1356 e metformina
EA021876B1 (ru) * 2010-09-20 2015-09-30 ЛИМОНОВ, Виктор Львович Фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, способ ее получения
ES2385158B1 (es) * 2010-12-24 2013-05-28 Arafarma Group, S.A. Composición farmacéutica de fosfomicina
CN102579466A (zh) * 2011-01-10 2012-07-18 王乐 一种磷霉素或磷霉素精氨酸盐与精氨酸的组合物
US8604078B2 (en) * 2011-04-06 2013-12-10 Carlos Picornell Darder Fosfomycin pharmaceutical composition
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
ITTO20130839A1 (it) * 2013-10-16 2015-04-17 C & G Farmaceutici S R L Composizione a base di fosfomicina trometamolo
DE102014218913A1 (de) 2014-09-19 2016-03-24 Heraeus Medical Gmbh Verfahren zur Herstellung eines antibiotischen Polymehtylmethacrylat-Knochenzementpulvers und ein antibiotisches Polymethtylmethacrylat-Knochenzementpulver
CN104546689B (zh) * 2015-01-07 2019-01-25 同方药业集团有限公司 一种含有甲硝唑的药物组合物
WO2017111718A1 (en) 2015-12-25 2017-06-29 Yusuf Toktamiş Öğün The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections
CA3147662A1 (en) 2021-02-10 2022-08-10 Labiana Health, S.L. New fosfomycin tablet formulations

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852434A (en) 1970-09-11 1974-12-03 Merck & Co Inc Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
IT1161974B (it) 1978-02-02 1987-03-18 Italchemi Spa Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
IT1112282B (it) 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1124610B (it) 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato
JPS59104326A (ja) 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
CH660305A5 (de) 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
WO1990003173A1 (en) * 1988-09-26 1990-04-05 Teijin Limited Stable aqueous preparation of active vitamin d¿3?
IT1231013B (it) * 1989-07-27 1991-11-08 Zambon Spa Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'.
US5191094A (en) 1989-07-27 1993-03-02 Zambon Group S.P.A. Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol) (2R,cis)-1,2-epoxypropyl-phosphonate with improved characteristics of stability and processing
IT1244543B (it) 1991-02-01 1994-07-15 La Fa Re Srl Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali
FR2690340B1 (fr) 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
JPH09183730A (ja) * 1995-05-10 1997-07-15 Meiji Seika Kaisha Ltd ホスホマイシン鏡像異性体を含んでなる医薬
DE19712565A1 (de) 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
UA82824C2 (uk) * 2000-06-21 2008-05-26 К'Юбіст Фармасьютікалз, Інк. Композиція і спосіб поліпшення перорального всмоктування протимікробних засобів
WO2002032459A2 (en) * 2000-10-17 2002-04-25 Massachusetts Institute Of Technology Method of increasing the efficacy of antibiotics by complexing with cyclodextrins
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
RU2003124299A (ru) 2005-01-20
ES2224869B1 (es) 2007-07-01
BRPI0302496C1 (pt) 2021-05-25
HRP20030618B1 (en) 2011-10-31
US20040022866A1 (en) 2004-02-05
FI120080B (sv) 2009-06-30
SE527466C2 (sv) 2006-03-14
NL1023790A1 (nl) 2004-02-03
FR2852845A1 (fr) 2004-10-01
SK9762003A3 (en) 2004-02-03
BRPI0302496B1 (pt) 2015-07-28
SK287201B6 (sk) 2010-03-08
BR0302496A (pt) 2004-08-24
JP4395338B2 (ja) 2010-01-06
CA2434927A1 (en) 2004-02-01
CH696718A5 (it) 2007-10-31
CO5480297A1 (es) 2005-01-28
CZ305023B6 (cs) 2015-04-01
SE0302129L (sv) 2004-02-02
PT102995B (pt) 2004-07-30
GR20030100300A (el) 2004-04-22
TR200301248A2 (tr) 2004-02-23
BE1017903A3 (fr) 2009-11-03
KR100966977B1 (ko) 2010-06-30
SE0302129D0 (sv) 2003-07-25
DK178348B1 (da) 2016-01-04
CZ20032096A3 (cs) 2004-03-17
AT500521A1 (de) 2006-01-15
ZA200305040B (en) 2004-05-11
CA2434927C (en) 2011-10-18
SI21259B (sl) 2012-12-31
HU230575B1 (hu) 2017-02-28
FI20031078A (sv) 2004-02-02
IL156615A (en) 2008-11-26
PL209644B1 (pl) 2011-09-30
PT102995A (pt) 2004-02-27
DE10334820A1 (de) 2004-03-11
RU2333000C2 (ru) 2008-09-10
ITMI20021725A1 (it) 2002-10-31
US7303755B2 (en) 2007-12-04
BRPI0302496B8 (pt) 2016-09-13
JP2004067682A (ja) 2004-03-04
KR20040012569A (ko) 2004-02-11
DK200301097A (da) 2004-02-02
ES2224869A1 (es) 2005-03-01
DE10334820B4 (de) 2020-02-06
HU0302441D0 (en) 2003-09-29
AT500521B1 (de) 2007-11-15
FR2852845B1 (fr) 2006-01-06
PL361518A1 (en) 2004-02-09
NL1023790C2 (nl) 2004-03-10
HRP20030618A2 (en) 2004-04-30
HUP0302441A2 (hu) 2005-07-28
SI21259A (sl) 2004-02-29
IL156615A0 (en) 2004-01-04

Similar Documents

Publication Publication Date Title
FI20011478A (sv) Farmaceutisk komposition
PT1501534E (pt) Formulacoes farmaceuticas
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK3494995T3 (da) Superfin formoterolformulering
ATE368042T1 (de) Cephemverbindungen
DE10393374D2 (de) Zusammensetzung
IS7381A (is) Efnasambönd
SE0500163L (sv) Sammansättning
IS7051A (is) Lyfjasamsetningar
DK1587478T3 (da) Farmaceutisk sammensætning
IS7414A (is) Oxó-azabísýklísk efnasambönd
DK1561472T3 (da) Faststofsammensætning
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
FI20031078A (sv) Farmaceutiska kompositioner med antibiotisk aktivitet
NO20045659L (no) Forbindelser
FI20022128A0 (sv) Farmaceutisk komposition
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
BR0310113B1 (pt) Composições pesticidas
IS7581A (is) Lyfjasamsetning
NO20034952D0 (no) Farmasöytiske forbindelser
DE60207587D1 (de) Weichmacherzusammensetzungen
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
GB0204392D0 (en) Pharmaceutical compound
NO20044164L (no) Farmasoytiske sammensetninger
EE200300378A (et) Farmatseutiline kompositsioon

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120080

Country of ref document: FI